Brian M. Hahn
2022
In 2022, Brian M. Hahn earned a total compensation of $918.2K as Chief Financial Officer and Senior Vice President at GlycoMimetics, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $103,120 |
|---|---|
| Non-Equity Incentive Plan | $193,001 |
| Option Awards | $169,920 |
| Salary | $443,450 |
| Other | $8,700 |
| Total | $918,191 |
Hahn received $443.5K in salary, accounting for 48% of the total pay in 2022.
Hahn also received $103.1K in bonus, $193K in non-equity incentive plan, $169.9K in option awards and $8.7K in other compensation.
Rankings
In 2022, Brian M. Hahn's compensation ranked 3,224th out of 5,756 executives tracked by ExecPay. In other words, Hahn earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,224 out of 5,756 | 44th |
Division Manufacturing | 1,812 out of 3,133 | 42nd |
Major group Chemicals And Allied Products | 862 out of 1,419 | 39th |
Industry group Drugs | 806 out of 1,320 | 39th |
Industry Pharmaceutical Preparations | 588 out of 966 | 39th |
Source: SEC filing on April 21, 2023.
Hahn's colleagues
We found two more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2022.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019